查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1722661

2025 年至 2033 年制酸劑市場報告（依藥物類別、劑型、配銷通路和地區）

Antacids Market Report by Drug Class, Formulation Type, Distribution Channel, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 134 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球制酸劑市場規模達 72 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 97 億美元，2025-2033 年期間的成長率 (CAGR) 為 3.4%。市場正在經歷成長，主要是因為零售藥局的擴張、對非處方藥的偏好以及患有胃食道逆流 (GERD) 的患者數量的增加推動了市場的成長。

制酸劑市場分析：

主要市場促進因素：全球患有胃食道逆流症 (GERD) 的人數正在增加，這刺激了對制酸劑的需求。這是推動市場成長的關鍵因素之一。

主要市場趨勢：主要參與者推出的西瓜薄荷、水果麥片和草莓奶昔等調味和咀嚼型抗酸藥對抗酸藥市場收入產生了積極影響。

地理趨勢：由於醫療支出增加、人口老化和醫療保健產業擴張，亞太地區是制酸劑最大的區域市場。

關鍵參與者：制酸劑產業的一些主要市場參與者包括雅培實驗室、阿斯特捷利康公司、拜耳公司、勃林格殷格翰國際有限公司、雷迪博士實驗室有限公司、葛蘭素史克公司、強生公司、輝瑞公司、寶潔公司、利潔時集團、賽諾菲公司、太陽製藥工業有限公司、武田藥品工業有限公司等。

挑戰與機會：制酸劑市場的挑戰在於存在治療胃酸倒流的替代療法，而機會則在於新興市場和治療消化問題的創新配方。

制酸劑市場趨勢：

胃食道逆流症（GERD）的影響

  • 美國國家醫學圖書館 2022 年的報告稱，2019 年有 7.8395 億人受到 GERD 的影響。遭受 GERD 折磨的人越多，對制酸劑的需求就越大。人們認為，治療酸性體質的最佳方法是使用制酸劑，因為它們具有多種特性。人們意識到制酸劑可以快速緩解症狀，而且其易於獲取，進一步促進了制酸劑市場的成長。

老年人口增加導致人口結構變化

老年人逐漸認知到制酸劑的重要性，因為它們能快速緩解酸性。因此，他們經常購買或服用制酸劑來治療這些消化問題。可以說，人口老化程度越高的國家，其制酸劑的全球銷售量就越高。根據世界衛生組織（WHO）2022年的報告，到2030年和2050年，每6個人中就有1人年齡在60歲或以上。全球60歲以上人口也將從2020年的14億增加到21億。

由於非處方藥 (OTC) 易於獲取，人們對其的依賴性日益增強

非處方藥物在世界各地很受歡迎，用於治療輕微症狀，這也刺激了對制酸劑的需求。制酸劑可透過藥局、雜貨店和線上平台輕鬆取得，因此在自我藥療中發揮著至關重要的作用。制酸劑具有成本效益和節省時間的優點，非常適合當今的人們。 IMARC Group的研究報告提到，到2032年，全球非處方藥（OTC）市場規模將達到2,759億美元。

制酸劑市場細分：

按毒品類別分類：

  • 質子幫浦抑制劑
  • H2拮抗劑
  • 酸中和劑
  • 促動力劑

質子幫浦抑制劑佔大部分市場佔有率

質子幫浦抑制劑非常有效可靠，每個人都希望它能減少胃酸和消化不良。醫療保健專業人員根據胃酸倒流的嚴重程度開出這些藥物，從而提高了其銷售量。主要參與者正在擴大他們的市場，因為他們知道人們正在逐漸了解質子幫浦抑制劑對身體的正面影響。例如，大元製藥於 2022 年在韓國推出了其首個質子幫浦抑制劑藥物 Escorten。

依配方類型分類：

  • 藥片
  • 液體
  • 粉末
  • 其他

平板電腦佔據產業最大佔有率

易於儲存、運輸和管理是平板電腦提供的一些優點，使其在個人中非常受歡迎。服用藥片非常方便，因為可以在任何地方或旅途中使用水輕鬆服用。無論是在辦公室、家中或旅行，人們都可以透過片劑藥物快速緩解胃酸或消化不良。與液體或粉末配方類型相比，片劑的保存期限延長被視為另一個好處。制酸劑市場上存在的各種片劑配方，如咀嚼片、緩釋片和發泡錠，進一步創造了強大的消費者群體。

依配銷通路分類：

  • 醫院藥房
  • 零售藥局
  • 其他

零售藥局是主要的細分市場

首先，世界各地的城市、郊區和農村都有大量的零售藥局。制酸劑作為非處方藥非常受歡迎，零售藥局是購買制酸劑的重要管道。其次，零售藥局提供多種抗酸藥物，可以滿足不同患者的喜好和需求。第三，零售藥局市場主要競爭對手專注於收購和擴張以擴大其影響力。 Medly Pharmacy 於 2021 年收購 Pharmaca 以提供 360 度藥房服務就是一個例子。

按地區分類：

  • 北美洲
  • 美國
  • 加拿大
  • 亞太
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 印尼
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中東和非洲

亞太地區引領市場，佔據制酸劑市場最大佔有率

該報告還對所有主要區域市場進行了全面的分析，包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告顯示，亞太地區佔據市場領先地位。

印度和中國等人口稠密的國家是該地區最大的制酸劑市場，因為這些國家正在經歷生活方式的轉變和西方飲食習慣，這通常會導致胃酸倒流和消化不良。此外，由於該地區老齡人口極易出現消化問題，因此被視為制酸劑市場近期的機會。與此相符的是，亞太地區有許多關鍵參與者，他們競爭激烈，並專注於合作和收購以擴大市場。印度製藥公司雷迪博士實驗室 (Dr. Reddy's Laboratories) 於 2024 年從 Amyris Inc. 收購了 MenoLabs，以滿足亞太地區人民不斷變化的需求。

競爭格局：

市場研究報告也對市場競爭格局進行了全面的分析。也提供了所有主要制酸劑公司的詳細資料。制酸劑產業的一些主要市場參與者包括：

  • 雅培實驗室
  • 阿斯特捷利康公司
  • 拜耳公司
  • 勃林格殷格翰國際股份有限公司
  • 雷迪博士實驗室有限公司
  • 葛蘭素史克公司
  • 強生公司
  • 輝瑞公司
  • 寶潔公司
  • 利潔時集團
  • 賽諾菲公司
  • 太陽製藥工業有限公司
  • 武田藥品工業株式會社。

（請注意，這僅代表部分公司名單，完整名單已在報告中提供。）

新配方和產品變體的開發由主要參與者透過研究和開發 (R&D) 活動完成。他們正在推出水果穀物等口味的抗酸藥物，以滿足消費者不斷變化的需求。頂級公司正在利用發展中國家人民對胃腸道健康的認知不斷提高這一機會。他們也著眼於收購市場上的小型企業，同時透過制酸劑市場的最新發展創造機會。使用數位健康解決方案是主要的幫助方法，使他們能夠提供更好的健康結果。阿斯特捷利康公司於 2023 年 11 月推出了一個這樣的例子，該公司成立了健康科技公司 Evinova，提供先進的數位健康解決方案。

本報告回答的關鍵問題

  • 制酸劑市場有多大
  • 2025-2033年全球制酸劑市場的預期成長率是多少
  • 推動全球制酸劑市場的關鍵因素有哪些
  • COVID-19 對全球制酸劑市場有何影響
  • 根據藥物類別，全球制酸劑市場如何分類
  • 根據劑型，全球制酸劑市場如何分類
  • 根據配銷通路，全球制酸劑市場如何分類
  • 全球制酸劑市場的主要區域有哪些
  • 全球制酸劑市場的主要參與者/公司有哪些

本報告回答的關鍵問題

  • 制酸劑市場有多大？ 2025 年至 2033 年期間全球制酸劑市場的預期成長率為何？
  • 推動全球制酸劑市場發展的關鍵因素有哪些？
  • COVID-19 對全球制酸劑市場有何影響？
  • 根據藥物類別，全球制酸劑市場是如何分類的？
  • 根據配方類型，全球制酸劑市場是如何分類的？
  • 根據配銷通路，全球制酸劑市場如何分佈？
  • 全球制酸劑市場的主要地區有哪些？
  • 全球制酸劑市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球制酸劑市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依藥品類別

  • 質子幫浦抑制劑
  • H2拮抗劑
  • 酸中和劑
  • 促動力劑

第7章：市場區隔：依配方類型

  • 藥片
  • 液體
  • 粉末
  • 其他

第8章：市場區隔：按配銷通路

  • 醫院藥房
  • 零售藥局
  • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • AstraZeneca plc
    • Bayer AG
    • Boehringer Ingelheim International GmbH
    • Dr. Reddy's Laboratories Ltd.
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Pfizer Inc.
    • Procter & Gamble Company
    • Reckitt Benckiser Group PLC
    • Sanofi SA
    • Sun Pharmaceutical Industries Ltd.
    • Takeda Pharmaceutical Company Limited
Product Code: SR112025A5082

The global antacids market size reached USD 7.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.7 Billion by 2033, exhibiting a growth rate (CAGR) of 3.4% during 2025-2033. The market is experiencing growth mainly because of the expansion of retail pharmacies, preference for OTC drugs, and rising number of patients experiencing gastroesophageal reflux disease (GERD) are impelling the growth of the market.

Antacids Market Analysis:

Major Market Drivers: People suffering from GERD is increasing around the world, which is catalyzing the demand for antacids. This represents one of the key factors propelling the market growth.

Key Market Trends: The launch of flavored and chewable antacids drugs by key players like watermelon mint, fruity cereals, and strawberry milkshake is positively impacting the antacids market revenue.

Geographical Trends: Asia Pacific is the largest regional market for antacids because of the rising healthcare expenditure, aging population, and healthcare sector expansion.

Key Players: Some of the major market players in the antacids industry include Abbott Laboratories, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc., Procter & Gamble Company, Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited., among many others.

Challenges and Opportunities: Challenges in the antacids market are the presence of alternative treatment for acid reflux, while opportunities lie in emerging markets and innovative formulations to treat digestive issues.

Antacids Market Trends:

Gastroesophageal reflux disease's (GERD) impact

  • 783.95 million people were impacted by GERD in 2019 claimed by the report of the National Library of Medicine 2022. The more people going through the suffering of GERD, the more it is driving the demand for antacids. The best treatment for acidity is thought to be antacids because of their several qualities. Individuals are aware about the quick relief provided by antacids and their easy accessibility is further contributing to the antacids market growth.

Changing demographics because of rising geriatric population

Elderly people are understanding the importance of antacids because of their quick relief qualities from acidity. They are, as a result, a regular consumer or buyer of antacids to manage these digestive issues. It may be said that nations with increased aging population rates can have higher sales of antacids worldwide. As claimed by the World Health Organization's (WHO) report of 2022, 1 individual out of 6 will be of 60 years in age or over by 2030 and by 2050. The global population of those aged 60 and over will also reach 2.1 billion, up from 1.4 billion in 2020.

Rising reliance on over the counter (OTC) medicines due to their ease of availability

Non-prescribed remedies are highly preferred in the world to cure mild symptoms, which is catalyzing the antacids demand. Antacids are easily available via pharmacies, grocery stores, and online platforms and as a result play a crucial role in self-medication purposes. The cost-effectiveness and time saving benefits provided by antacids are making them highly suitable for people nowadays. The IMARC Group's research report mentions that the global market for over the counter (OTC) drugs will reach US$ 275.9 Billion by 2032.

Antacids Market Segmentation:

Breakup by Drug Class:

  • Proton Pump Inhibitors
  • H2 Antagonist
  • Acid Neutralizers
  • Pro-Motility Agents

Proton pump inhibitors accounts for the majority of the market share

Proton pump inhibitors are so effective and reliable that everyone wants them to cut down on stomach acid and indigestion. Healthcare professionals prescribed them as per the severity of acid reflux, leading to their higher sales. Key players are expanding their market as they know people are gaining knowledge about the positive impact of proton pump inhibitors in the body. For instance, Daewon Pharmaceutical introduced its first proton pump inhibitor medicine in Korea in 2022, known as Escorten.

Breakup by Formulation Type:

  • Tablet
  • Liquid
  • Powder
  • Others

Tablet holds the largest share of the industry

Easy storage, transportation, and administration are some benefits provided by tablets make them highly preferable among individuals. Tablets are hassle-free, as they can be easily consumed with water anywhere or on the go. Whether at office, home, or travel, people can get quick relief from acidity or indigestion through tablet drugs. The extended shelf life of tablets is viewed as another benefit compared to liquid or powder formulation type. Various tablets formulations present in the antacids market like chewable, delayed release, and effervescent are further creating a strong consumer base.

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

Retail pharmacies represent the leading market segment

In the first place, cities, suburbs, and rural areas all have numerous retail pharmacies around the world. Antacids as OTC drugs are highly popular & retail pharmacies are a significant outlet to purchase antacids. Secondly, the inclusion of a wide variety of antacids drugs in retail pharmacies can cater to several patients according to their preferences and demands. Thirdly, the focus of leading competitors in the retail pharmacy market on acquisition & expansion to increase their reach. The acquisition of Pharmaca by Medly Pharmacy in 2021 to deliver 360-degrees pharmacy services is one such example.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Asia Pacific leads the market, accounting for the largest antacids market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific enjoys the leading position in the market.

The densely populated countries like India and China are the largest markets for antacids in this region, as these countries are undergoing lifestyle shifts and Western food habits, which generally results in acid reflux and indigestion. Moreover, aging population in the region is viewed as an antacids market recent opportunities due to their high susceptibility to digestive issues. In line with this, lots of key players are present in the Asia Pacific region that are highly competitive and focus on partnerships and acquisition to expand their market. This was done by Dr. Reddy's Laboratories, a pharma company in India, when it acquired MenoLabs from Amyris Inc. in 2024 to cater to the evolving needs of people in the Asia Pacific region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major antacids companies have also been provided. Some of the major market players in the antacids industry include:

  • Abbott Laboratories
  • AstraZeneca plc
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Dr. Reddy's Laboratories Ltd.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Pfizer Inc.
  • Procter & Gamble Company
  • Reckitt Benckiser Group PLC
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited.

(Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.)

The development of new formulations and product variants is done by key players through research and development (R&D) activities. They are introducing antacid drugs with flavors such as Fruity Cereal to meet the evolving demands of consumers. Top companies are taking advantage of elevated awareness about gastrointestinal health among people in developing countries. They are also eyeing on acquiring small businesses in the market while creating opportunities via antacids market recent developments. Using the digital health solutions is the main help method, enabling them to provide better health results. One such example was presented by AstraZeneca in November 2023, which it launched Evinova, a health-tech business, to offer advanced digital health solutions.

Key Questions Answered in This Report

  • 1.How big is the antacids market?
  • 2.What is the expected growth rate of the global antacids market during 2025-2033?
  • 3.What are the key factors driving the global antacids market?
  • 4.What has been the impact of COVID-19 on the global antacids market?
  • 5.What is the breakup of the global antacids market based on the drug class?
  • 6.What is the breakup of the global antacids market based on the formulation type?
  • 7.What is the breakup of the global antacids market based on the distribution channel?
  • 8.What are the key regions in the global antacids market?
  • 9.Who are the key players/companies in the global antacids market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Antacids Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Class

  • 6.1 Proton Pump Inhibitors
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 H2 Antagonist
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Acid Neutralizers
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Pro-Motility Agents
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Formulation Type

  • 7.1 Tablet
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Liquid
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Powder
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 AstraZeneca plc
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Bayer AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Boehringer Ingelheim International GmbH
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Dr. Reddy's Laboratories Ltd.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 GlaxoSmithKline plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Johnson & Johnson
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Pfizer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Procter & Gamble Company
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Reckitt Benckiser Group PLC
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Sanofi S.A.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Sun Pharmaceutical Industries Ltd.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 Takeda Pharmaceutical Company Limited
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Antacids Market: Major Drivers and Challenges
  • Figure 2: Global: Antacids Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Antacids Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Antacids Market: Breakup by Drug Class (in %), 2024
  • Figure 5: Global: Antacids Market: Breakup by Formulation Type (in %), 2024
  • Figure 6: Global: Antacids Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Antacids Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Antacids (Proton Pump Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Antacids (Proton Pump Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Antacids (H2 Antagonist) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Antacids (H2 Antagonist) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Antacids (Acid Neutralizers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Antacids (Acid Neutralizers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Antacids (Pro-Motility Agents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Antacids (Pro-Motility Agents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Antacids (Tablet) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Antacids (Tablet) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Antacids (Liquid) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Antacids (Liquid) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Antacids (Powder) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Antacids (Powder) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Antacids (Other Formulation Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Antacids (Other Formulation Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Antacids (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Antacids (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Antacids (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Antacids (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Antacids (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Antacids (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: North America: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: North America: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: United States: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: United States: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Canada: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Canada: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Asia-Pacific: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Asia-Pacific: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: China: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: China: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Japan: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Japan: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: India: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: India: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: South Korea: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: South Korea: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Australia: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Australia: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Indonesia: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Indonesia: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Others: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Others: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Europe: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Europe: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Germany: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Germany: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: France: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: France: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: United Kingdom: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: United Kingdom: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Italy: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Italy: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Spain: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Spain: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Russia: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Russia: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Latin America: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Latin America: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Brazil: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Brazil: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Mexico: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Mexico: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Middle East and Africa: Antacids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Middle East and Africa: Antacids Market: Breakup by Country (in %), 2024
  • Figure 78: Middle East and Africa: Antacids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Global: Antacids Industry: SWOT Analysis
  • Figure 80: Global: Antacids Industry: Value Chain Analysis
  • Figure 81: Global: Antacids Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Antacids Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Antacids Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
  • Table 3: Global: Antacids Market Forecast: Breakup by Formulation Type (in Million USD), 2025-2033
  • Table 4: Global: Antacids Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Antacids Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Antacids Market: Competitive Structure
  • Table 7: Global: Antacids Market: Key Players